Fairvalue-Calculator Fairvalue-Calculator
EN DE

Leveljump Healthcare Corp (JMPHF) Fair Value & Analysis

Healthcare · US · Market cap $34.7M

Price$0.0428
Fair Value$0.0330
Upside-22.8%
Quality92/100
Evidence: High Range $0.0288 – $0.0330

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Leveljump Healthcare Corp (JMPHF) currently trades at $0.0428, while our model-based Fair Value estimate is $0.0330 — implying the stock looks roughly 22.8% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Leveljump Healthcare Corp., together with its subsidiaries, provides radiology services. The company offers direct patient images and teleradiology services; in-patient diagnostic imaging facilities, including x-rays, ultrasounds, and mammography; and other medical services. It serves hospitals and clinics. Leveljump Healthcare Corp. is headquartered in Toronto, Canada.

Open the full interactive analysis →

Similar stocks

Thermo Fisher Scientific Inc (TMO) -96% Danaher Corporation (DHR) -52% WuXi AppTec Co (WUXAY) +35% IDEXX Laboratories, Inc (IDXX) -66% Lonza Group (LZAGY) -59% Agilent Technologies, Inc (A) -54%

Frequently asked questions

Is Leveljump Healthcare Corp (JMPHF) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $0.0330 versus a price of $0.0428 — about −23% (overvalued). Model-based estimate, not financial advice.
What is the fair value of JMPHF?
Our 21-model fair value for Leveljump Healthcare Corp is $0.0330 (as of Jun 26, 2026), built from audited fundamentals. The current price is $0.0428.
What is the quality score of JMPHF?
Leveljump Healthcare Corp has a Quality Score of 92/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.